Partner with Taiho Oncology to Improve the Lives of Cancer Patients

TOI OFFERS DEEP EXPERIENCE AND STRONG CAPABILITIES THAT MAXIMIZE THE POTENTIAL OF OUR PARTNERS’ ASSETS

  • Taiho Oncology is a rapidly growing company whose intense focus on improving life for cancer patients drives all of our efforts
  • Deep cancer expertise and functional experience offered by our team – drawn from leading oncology companies across the biopharmaceutical industry
  • Strong development, lifecycle management and biomarker capabilities - which means maximizing the clinical potential of your asset
  • Highly collaborative culture and approach to partnering
  • Nimble, rapid decision-making and execution of a small company
  • Backed by the substantial resources and capabilities of our parent companies
  • Proven commercialization track record of success in the US oncology market
  • Expansion into Europe for future opportunities

OUR BUSINESS DEVELOPMENT STRATEGY AND PRIORITIES


IN-LICENSING AND ACQUIRING LATE STAGE AND MARKETED ONCOLOGY PRODUCTS MEETING SIGNIFICANT UNMET PATIENT NEEDS

>Indication Focus

  • Solid tumors – across tumor types
  • Hematological malignancies

>Therapeutic Approach

  • Focus on small molecules, but agnostic across therapeutic modalities
  • Open to mechanistic approaches – data driven
  • Biomarker precision medicine-driven approaches valued

>Development Stage

  • Post-proof of concept
  • Ideally in registrational trial(s) supporting initial approval
  • Marketed products – including “tail products”
  • Assets deprioritized for strategic reasons

>Geographic Field

  • U.S.
  • Canada
  • Europe
  • Japan/Asia – with our parent Taiho Pharmaceutical Company

Proven Capabilities in the US Market

Contact Us


TAIHO ONCOLOGY, INC.
Head Office: 101 Carnegie Center, Suite 101
Princeton, New Jersey 08540

Tel: 609-750-5300

Email: BD@taihooncology.com (to be used strictly for communicating non-confidential information about potential business partnership opportunities)

Steven Yoder

Learn more about Taiho Oncology and its business development priorities:


Nature Bio Pharm Dealmakers MAR 2021

TOI Business Development Presentation



We look forward to hearing from you!